Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.39
-0.03 (-0.47%)
Nov 17, 2026, 4:00 PM EST - Market closed
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Lifecore Biomedical stock have an average target of $6.28, which predicts a -1.72% decrease from the current stock price of 6.39.
Price Target: $6.28 (-1.72%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Sep 28, 2026.
Analyst Ratings
The average analyst rating for Lifecore Biomedical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 4, 2026 |
| William Blair | William Blair | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 3, 2026 |
| Craig-Hallum | Craig-Hallum | Hold Downgrades $6.28 | Hold | Downgrades | $6.28 | -1.72% | Sep 28, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 6, 2026 |
Financial Forecast
Revenue This Year
120.57M
from 128.87M
Decreased by -6.87%
Revenue Next Year
131.39M
from 120.57M
Increased by 8.97%
EPS This Year
-0.74
from -0.43
EPS Next Year
-0.72
from -0.74
EPS and Forward PE are based on non-GAAP adjusted numbers.